Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Prenat Diagn ; 29(9): 852-6, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19441088

ABSTRACT

OBJECTIVE: To study pregnant women's preference among various screening options for Down syndrome (DS) in routine clinical setting, and its potential association with women's demographic characteristics. METHODS: Women aged 35 years and older carrying singleton pregnancy were offered a variety of screening tests for DS before 14 weeks of gestation. Their preference was confirmed by the test they actually underwent. The association between women's choice of test and a number of demographic characteristics was studied using multinomial regression. RESULTS: Among 1967 eligible women, 619 opted for first-trimester screening test (FTS), 924 for partial integrated test (PIT), and 424 for full integrated test (FIT). Nulliparous women and working mothers were more likely to choose FTS and FIT. Women with history of subfertility were more likely to choose FIT. Women with family history of chromosomal abnormalities were more likely to choose FTS. The choice of screening test could be predicted for 49.9% of women using four demographic characteristics. CONCLUSIONS: Among older women of predominantly Chinese ethnicity, integrated test is a favorite alternative to FTS. Their choice of DS screening test can be predicted by their obstetric and socioeconomic characteristics. Many women show willingness to pay for a test with a lower false-positive rate.


Subject(s)
Down Syndrome/diagnosis , Patient Preference , Prenatal Diagnosis/methods , Adult , Female , Health Knowledge, Attitudes, Practice , Humans , Mass Screening/economics , Mass Screening/methods , Mass Screening/psychology , Maternal Age , Middle Aged , Patient Preference/economics , Patient Preference/statistics & numerical data , Pregnancy , Pregnancy Trimester, First , Prenatal Diagnosis/economics , Prenatal Diagnosis/psychology , Reproductive Medicine , Socioeconomic Factors
2.
Singapore Med J ; 43(8): 415-20, 2002 Aug.
Article in English | MEDLINE | ID: mdl-12507028

ABSTRACT

BACKGROUND: Several nucleic acid amplification (NAA) tests are available for the rapid detection of Mycobacterium tuberculosis (MTB) in clinical specimens. AIMS: To identify the pattern of utilisation and accuracy of the AMPLICOR test in routine clinical practice in an acute care setting. DESIGN: A retrospective descriptive study. METHOD: We studied 159 consecutive specimens in which the AMPLICOR (Roche; Branchburg, NJ) test was requested by attending doctors. The sensitivities and specificities of the AMPLICOR for detection of active tuberculosis (TB) were calculated in relation to types of specimens, smear and culture results. RESULTS: The number of requests more than doubled from 1999 to 2000. Thirty-eight percent of the specimens were not from the respiratory tract. The majority of the specimens had requests for one or more additional test (mean 1.8). The rate of active TB was 18%. The sensitivities of the AMPLICOR on per specimen, per patient, per smear negative specimen and per smear negative patient basis were found to be 81%, 80%, 66.7% and 71.4% respectively. The specificities for these groups accordingly were 99%, 98.6%, 99% and 98.6% respectively. The sensitivity and specificity for respiratory specimens were 97.5% and 98.5%, while for non-respiratory specimens, they were 60% and 100%. In smear negative specimens, the sensitivity and specificity for respiratory specimens were 60% and 98.5%, while for non-respiratory specimens, they were 75% and 100%. The AMPLICOR assay was negative in all 21 specimens of pleural or spinal fluid. CONCLUSIONS: There is a growing demand for NAA in the rapid diagnosis of TB with a high proportion of non-respiratory specimens. The number of additional diagnostic tests performed on each specimen should be limited. In routine clinical practice, the AMPLICOR assay is a useful confirmatory test for active pulmonary TB. The utility of the AMPLICOR assay for MTB detection in exudative fluid specimens needs further evaluation.


Subject(s)
Mycobacterium tuberculosis/isolation & purification , Nucleic Acid Amplification Techniques , Reagent Kits, Diagnostic , Tuberculosis, Pulmonary/diagnosis , Tuberculosis/diagnosis , Hospitals, University , Humans , Laboratories, Hospital , Nucleic Acid Amplification Techniques/statistics & numerical data , Polymerase Chain Reaction/methods , Professional Practice , Reagent Kits, Diagnostic/statistics & numerical data , Reproducibility of Results , Retrospective Studies , Sensitivity and Specificity , Singapore , Sputum/microbiology
3.
J Dairy Sci ; 80(2): 413-21, 1997 Feb.
Article in English | MEDLINE | ID: mdl-9058285

ABSTRACT

The combination of penicillin and novobiocin is currently available for the treatment of bovine mastitis, but methods are not available for susceptibility testing of the combination by veterinary diagnostic laboratories. The minimum inhibitory concentration (MIC) and disk diffusion data were determined for penicillin, novobiocin, and a combination of the two in a 1:2 ratio for 225 staphylococcal, streptococcal, and Gram-negative isolates from bovine intramammary infections. Based on the drug concentrations in milk following infusion, linear regression analysis, and error rate bounding, the interpretive zone diameters selected were < or = 16 mm for resistant isolates and > or 17 mm for susceptible isolates with a disk containing 10 U of penicillin and 30 micrograms of novobiocin. Additionally, MIC breakpoints of < or = 2 micrograms/ml of penicillin and 4 micrograms/ml of novobiocin were selected to categorize isolates as susceptible and > or = 4 micrograms/ml of penicillin and 8 micrograms/ml of novobiocin were selected to categorize isolates as resistant. The MIC and disk diffusion results, as well as studies to monitor bacterial killing by antimicrobial agents over time, indicated that the combination of penicillin and novobiocin in a 1:2 ratio was more active than were the individual drugs. Kinetics of the kill curves with the penicillin and novobiocin combination (1:2 ratio) showed that the combination was bactericidal for Staphylococcus aureus and Staphylococcus xylosus.


Subject(s)
Anti-Bacterial Agents/pharmacology , Mastitis, Bovine/microbiology , Microbial Sensitivity Tests , Novobiocin/pharmacology , Penicillins/pharmacology , Animals , Anti-Bacterial Agents/administration & dosage , Cattle , Diffusion , Drug Therapy, Combination , Female , Mastitis, Bovine/drug therapy , Novobiocin/administration & dosage , Penicillins/administration & dosage , Staphylococcus/drug effects , Streptococcus/drug effects
4.
J Antimicrob Chemother ; 38(1): 133-7, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8858465

ABSTRACT

We sought to study the nature of rifampicin resistance in Pseudomonas aeruginosa. We hypothesized that the rifamycin regions of RNA polymerase are conserved in P. aeruginosa and that rifampicin resistance is mediated by a mutation in the rpoB gene encoding the beta subunit of RNA polymerase. Transcription assays showed that 50 nM of rifampicin inhibited transcription > 99% in a clinical isolate (MIC = 32 mg/L) and only < 40% in the rifampicin resistant mutant (MIC = 1000 mg/L). DNA sequencing revealed that the rifampicin regions are conserved in P. aeruginosa and the rifampicin regions of the rifampicin-resistant strain contained a mutation. Sodium hexametaphosphate lowered rifamycin MIC in a rifamycin-resistant mutant four-fold and in the clinical isolate 32-fold, suggesting that P. aeruginosa has a natural membrane barrier to rifamycins.


Subject(s)
Anti-Bacterial Agents/pharmacology , Phosphates/pharmacology , Pseudomonas aeruginosa/drug effects , Rifampin/analogs & derivatives , Rifamycins/pharmacology , Transcription, Genetic/drug effects , Amino Acid Sequence , Drug Resistance, Microbial/genetics , Microbial Sensitivity Tests , Molecular Sequence Data , Mutation , Pseudomonas aeruginosa/genetics , Rifampin/pharmacology , Sequence Homology, Amino Acid
5.
Am J Med ; 100(6A): 26S-38S, 1996 Jun 24.
Article in English | MEDLINE | ID: mdl-8678094

ABSTRACT

In a surveillance study conducted during 1992-1993 at 83 medical institutions of different types and sizes (e.g., laboratories, community hospitals, teaching hospitals) and from different geographical areas of the United States, clinical bacterial isolates were tested for their susceptibility to eight comparative antimicrobial agents (cefepime, ceftazidime, cefotaxime, ceftriaxone, ciprofloxacin, gentamicin, imipenem, and piperacillin). A total of 12,574 isolates were tested by either the Etest method (AB Biodisk) or a microdilution method (MicroScan) in the participating laboratories; 11.8% of these isolates were subsequently retested for quality assurance purposes by both methods in a central laboratory. The results obtained in the central laboratory were essentially the same as the results obtained in the participating laboratories. This article presents data for gram-negative and gram-positive isolates other than Streptococcus pneumoniae, the results of which have been previously published. Antimicrobial susceptibility results obtained with the two different minimum inhibitory concentration (MIC) methods--MicroScan and Etest--showed that most isolates of Enterobacteriaceae were susceptible to cefepime, exceeding the activity of ceftazidime, ceftriaxone, and cefotaxime, principally because of the greater activity of cefepime against the species that produce Bush group 1 beta-lactamases (predominantly Enterobacter cloacae, Enterobacter aerogenes, and Citrobacter freundii). In addition, the activity of cefepime against Pseudomonas aeruginosa isolates was essentially equivalent to that of ceftazidime and greater than that of third-generation cephalosporins. Most methicillin-susceptible Staphylococcus aureus were susceptible to all the cephalosporins, whereas methicillin-resistant S. aureus and enterococci were resistant. Overall, the most active antimicrobials in this study were imipenem, ciprofloxacin, and cefepime, but the activity of all the antimicrobials varied with different species. Categorically, the results from the microdilution and Etest methods were equivalent.


Subject(s)
Anti-Bacterial Agents/pharmacology , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Anti-Bacterial Agents/antagonists & inhibitors , Dose-Response Relationship, Drug , Drug Resistance, Microbial , Gram-Negative Bacteria/isolation & purification , Gram-Positive Bacteria/isolation & purification , Humans , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests/statistics & numerical data , Random Allocation , United States
7.
J Antimicrob Chemother ; 32 Suppl B: 13-9, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8150756

ABSTRACT

Using the national surveillance programme of USA hospitals, we selected 162 strains of Streptococcus pneumoniae for sensitivity testing using the NCCLS breakpoints for benzylpenicillin and the oxacillin discs screen test. Included in the group of isolates were 85 relatively penicillin-resistant and 33 penicillin-resistant strains. The activity of cefepime, a new cephalosporin, was compared with other cephalosporins and penicillins as well as some non-beta-lactam antimicrobials. Imipenem was the most active agent but, cefepime, cefotaxime, ceftriaxone and ciprofloxacin were only slightly less active. The least active agents were ceftazidime, cefuroxime, piperacillin/tazobactam and ticarcillin/clavulanate. Cefepime is a potential alternative treatment to penicillin, particularly when penicillin-resistant and relatively penicillin-resistant S. pneumoniae are encountered. The clinical importance of screening for penicillin resistance by the use of the oxacillin disc is emphasized.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cephalosporins/pharmacology , Penicillin Resistance/physiology , Streptococcus pneumoniae/drug effects , Cefepime , Humans , Microbial Sensitivity Tests , Oxacillin/pharmacology , Pneumococcal Infections/microbiology
8.
J Antimicrob Chemother ; 32 Suppl B: 31-53, 1993 Nov.
Article in English | MEDLINE | ID: mdl-8150766

ABSTRACT

Cefepime, a new cephalosporin which has a broad-spectrum of activity was tested in vitro against 1961 Gram-positive and Gram-negative clinical isolates obtained from European hospitals. Cefepime was highly active against Gram-negative organisms, inhibiting over 94% of strains tested. The overall susceptibility rate for cefepime against all isolates was 81%. Cefepime was more active than any of the third-generation cephalosporins tested against species capable of producing type I beta-lactamases, e.g. Enterobacter cloacae, Citrobacter freundii, and Enterobacter aerogenes. The activity of cefepime against Pseudomonas aeruginosa was similar to that of ceftazidime and substantially greater than those of cefotaxime and ceftriaxone. All cephalosporins except ceftazidime exhibited high activity against methicillin-susceptible Staphylococcus aureus but poor activity was observed against methicillin-resistant strains. Overall susceptibility to cefepime is lower in Europe than it is in North America.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Cephalosporins/pharmacology , Bacteria/enzymology , Bacterial Infections/epidemiology , Bacterial Infections/microbiology , Cefepime , Europe , Humans , Methicillin Resistance , Microbial Sensitivity Tests , Penicillinase/biosynthesis
9.
Infect Control Hosp Epidemiol ; 13(12): 706-10, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1337751

ABSTRACT

OBJECTIVES: To elucidate the epidemiology of widespread ciprofloxacin resistance in our Veterans Affairs medical center using whole cell DNA analysis. DESIGN: In vitro study of ciprofloxacin resistant and susceptible Enterobacteriaceae isolated during the course of a clinical epidemiologic study of quinolone resistance. SETTING: Veterans Affairs Medical Center with acute care and long-term care divisions. RESULTS: We examined 40 ciprofloxacin-resistant strains of Serratia marcescens, Proteus mirabilis, and Providencia stuartii using restriction endonuclease analysis of whole cell DNA and compared them with concomitantly isolated ciprofloxacin sensitive strains. We sought to determine whether resistant strains were identical to susceptible strains, indicating in vivo emergence of resistant strains from susceptible strains, and whether resistant strains were shared among patients. All 26 ciprofloxacin-resistant S marcescens isolates shared a single ecoRI restriction pattern. Multiple patterns were seen in the ciprofloxacin-susceptible S marcescens isolates; however, several isolates had a pattern matching that of the resistant isolates. Similar results were seen among the P mirabilis isolates. Three different ecoRI patterns were found among the ciprofloxacin-resistant P stuartii isolates; none matched those found among the susceptible isolates. The frequency of spontaneous emergence of ciprofloxacin resistance in susceptible S marcescens strains with restriction pattern matching that of the resistant strains was significantly higher than that of nonmatching strains. CONCLUSIONS: Ciprofloxacin-resistant strains of Enterobacteriaceae became widespread within a short period of time. Resistant strains of S marcescens and P mirabilis arose from endemic susceptible strains. The resistant strain of S marcescens appeared to arise from a susceptible strain with a relatively high frequency of spontaneous ciprofloxacin resistance.


Subject(s)
Ciprofloxacin/pharmacology , DNA, Bacterial/genetics , Enterobacteriaceae/drug effects , Case-Control Studies , DNA Restriction Enzymes/genetics , Drug Resistance, Microbial , Enterobacteriaceae/genetics , Hospitals, Veterans , Humans , Microbial Sensitivity Tests , Serratia marcescens/drug effects , Serratia marcescens/genetics
10.
Chest ; 102(5): 1601-3, 1992 Nov.
Article in English | MEDLINE | ID: mdl-1424901

ABSTRACT

A patient undergoing esophageal dilatation for carcinoma of the esophagus suffered esophageal perforation and development of an empyema. Culture of pleural fluid yielded multiple organisms, including Legionella pneumophila serogroup 5. Epidemiologic investigation showed that the source of L pneumophila was a tap used by the nursing personnel to fill patients' water pitchers. Whole-cell restriction endonuclease analysis of DNA from the clinical and environmental isolates of L pneumophila serogroup 5 yielded identical patterns. Our findings suggest that L pneumophila was acquired by the patient at least 12 h prior to the procedure causing the esophageal perforation and empyema, suggesting that the organism can persist in an infectious form in the upper aerodigestive tract.


Subject(s)
Cross Infection , Empyema, Pleural/microbiology , Esophageal Perforation/complications , Esophagus/injuries , Legionella pneumophila/isolation & purification , Legionnaires' Disease/transmission , Aged , Dilatation/adverse effects , Empyema, Pleural/etiology , Esophageal Perforation/etiology , Esophagoscopy/adverse effects , Humans , Male , Water Microbiology , Water Supply
11.
Transfusion ; 32(8): 771-4, 1992 Oct.
Article in English | MEDLINE | ID: mdl-1412688

ABSTRACT

Septicemia is a rare complication of platelet transfusion. A case is reported of transfusion-associated septicemia in a 66-year-old man who received a 10-unit pool of platelets. During transfusion, he experienced rigors, wheezing, dyspnea, and fever. A total of four blood cultures drawn 10 and 36 hours after discontinuation of the transfusion grew Staphylococcus epidermidis. Culture of the residual platelet pool yielded S. epidermidis with a colony count of 10(5) organisms per mL. Strain identity of all four blood isolates and the platelet pool isolate was confirmed by gel electrophoresis of EcoRI and HindIII restriction digests of whole-cell DNA. There have been 31 prior reported cases of platelet transfusion-associated septicemia, of which 9 have been caused by coagulase-negative staphylococci. Systemic reactions to platelet transfusions should prompt consideration of transfusion-associated bacteremia as the cause.


Subject(s)
Blood Component Transfusion/adverse effects , Blood Platelets/microbiology , Sepsis/etiology , Staphylococcal Infections/etiology , Staphylococcus epidermidis , Aged , DNA, Bacterial/analysis , Humans , Male , Staphylococcus epidermidis/isolation & purification
12.
Epidemiol Infect ; 109(1): 49-57, 1992 Aug.
Article in English | MEDLINE | ID: mdl-1499672

ABSTRACT

Although cases of community-acquired Legionnaires' disease have been epidemiologically linked to residential water supplies, the risk of acquiring Legionnaires' disease from exposure to Legionella pneumophila in residential water systems is uncertain. The residential water supplies of 218 members of the American Legion in six different geographical areas in Pittsburgh were cultured for L. pneumophila. Residents of the homes provided a recent medical history and a blood sample for detection of antibodies to legionella. A urine sample for legionella urinary antigen testing was also requested from individuals residing in legionella-positive homes and individuals with a positive antibody test. Six percent (14/218) of the homes yielded L. pneumophila (range within six areas 0-22%). Lower hot water tank temperature was significantly associated with legionella positivity (P less than 0.01). Analysis of water samples for mineral content showed no association between legionella positivity and concentrations of calcium and magnesium. Water samples from the area where 22% of the homes surveyed were positive for legionella had a higher iron content than water samples from the other areas tested. None of the individuals residing in legionella-positive homes showed elevated antibody titres to legionella or the presence of legionella antigen in urine. For the immunocompetent hosts, the risk of contracting Legionnaires' disease from exposure to contaminated household water supplies in the Pittsburgh area appears to be low.


Subject(s)
Legionella pneumophila/isolation & purification , Legionnaires' Disease/epidemiology , Water Microbiology , Water Supply , Adult , Aged , Aged, 80 and over , Antibodies, Bacterial/blood , Antigens, Bacterial/urine , Hot Temperature , Humans , Legionella pneumophila/immunology , Middle Aged , Minerals/analysis , Multivariate Analysis , Prevalence , Water Supply/analysis
13.
Ann Intern Med ; 114(2): 107-12, 1991 Jan 15.
Article in English | MEDLINE | ID: mdl-1984384

ABSTRACT

OBJECTIVE: To determine the natural history of colonization by methicillin-resistant Staphylococcus aureus (MRSA) among patients in a long-term care facility. We specifically sought to determine if MRSA colonization was predictive of subsequent infection. DESIGN: Cohort study. SETTING: Long-term Veterans Affairs Medical Center. PATIENTS: A total of 197 patients residing on two units were followed with regular surveillance cultures of the anterior nares. MAIN OUTCOME MEASUREMENT: The development of staphylococcal infection. RESULTS: Thirty-two patients were persistent carriers of MRSA and 44 were persistent carriers of methicillin-susceptible strains (MSSA). Twenty-five percent of MRSA carriers had an episode of staphylococcal infection compared with 4% of MSSA carriers and 4.5% of non-carriers (P less than 0.01; relative risk 3.8; 95% CI, 2.0 to 6.4). The rate of development of infection among MRSA carriers was 15% for every 100 days of carriage. Using logistic regression analysis, persistent MRSA carriage was the most significant predictor of infection (P less than 0.001; odds ratio, 3.7). Seventy-three percent of all MRSA infections occurred among MRSA carriers. Isolates of MRSA from 7 patients were typed. Colonizing and infecting strains had the same phage type in all 7 patients and the same pattern of plasmid EcoRI restriction endonuclease fragments in 5 patients. CONCLUSIONS: Colonization of the anterior nares by MRSA predicts the development of staphylococcal infection in long-term care patients; most infections arise from endogenously carried strains. Colonization by MRSA indicates a significantly greater risk for infection than does colonization by MSSA. The results offer a theoretic rationale for reduction in MRSA infections by interventions aimed at eliminating the carrier state.


Subject(s)
Carrier State/epidemiology , Cross Infection/epidemiology , Methicillin Resistance , Staphylococcal Infections/epidemiology , Staphylococcus aureus/classification , Aged , Aged, 80 and over , Bacteriophage Typing , Carrier State/microbiology , Cross Infection/microbiology , Humans , Middle Aged , Nose/microbiology , Nursing Homes , Plasmids , Prospective Studies , Staphylococcal Infections/microbiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/isolation & purification
14.
Am Ind Hyg Assoc J ; 49(11): 584-90, 1988 Nov.
Article in English | MEDLINE | ID: mdl-3195473

ABSTRACT

Legionnaires' disease is a severe pneumonia caused by the bacterium Legionella pneumophila. Outbreaks of Legionnaire's disease have occurred in hotels, hospitals, and homes but had not been reported yet in the work environment. The authors report the occurrence of Legionnaires' disease in three employees of two industrial plants. The potable water in the two plants contained high numbers of Legionella pneumophila. Monoclonal antibody subtyping of environmental and patient isolates of L. pneumophila implicated one of the plants as the source for the disease. L. pneumophila was eradicated from this plant using acidic and caustic scale removers, calcium hypochlorite, and a biocide. A systematic approach to Legionnaires' disease in the work environment, a problem which can be expected to be recognized with increasing frequency, is presented.


Subject(s)
Legionnaires' Disease/epidemiology , Occupational Diseases/epidemiology , Antibodies, Monoclonal , Disinfection/methods , Female , Humans , Legionella/isolation & purification , Legionnaires' Disease/prevention & control , Male , Middle Aged , Occupational Diseases/prevention & control , Serologic Tests , Water Microbiology
16.
Antimicrob Agents Chemother ; 30(1): 174-5, 1986 Jul.
Article in English | MEDLINE | ID: mdl-3638931

ABSTRACT

We studied the interaction between rifampin and fusidic acid against a group of staphylococci. Of the 20 coagulase-positive strains studied, checkerboard studies revealed synergy in 3 and indifference in 17; time-kill studies revealed synergy in 18 of 19 coagulase-positive strains at both 24 and 48 h. Of the 19 coagulase-negative strains, checkerboard studies revealed synergy in 6 and indifference in 13; time-kill studies revealed synergy in 6 of 18 coagulase-negative strains at 24 h and in 17 of 18 coagulase-negative strains at 48 h. The combination of rifampin and fusidic acid warrants further evaluation in the therapy of staphylococcal disease.


Subject(s)
Fusidic Acid/pharmacology , Methicillin/pharmacology , Rifampin/pharmacology , Staphylococcus/drug effects , Coagulase/metabolism , Drug Synergism , Microbial Sensitivity Tests , Penicillin Resistance , Staphylococcus/enzymology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...